Skip to content
Homepage
Clinic directory

Clinics in Glendale, Arizona

Every listing is checked against federal records, reviewed for evidence, and confirmed still operating. No pay-to-play. No guesswork.

  • No results found.
  • No results found.

Glendale, AZ

Stem Cell Therapy clinics in Glendale

Glendale supports a regenerative medicine market shaped by both private clinics and regional academic medicine. Local referral networks run through Adventist Health Glendale, USC Verdugo Hills, and nearby Keck Medicine, and stem cell practice in the area spans Brand Boulevard, the Americana area, and Montrose border. Patient demand splits across three buckets: orthopedic injections for active adults and aging athletes, neurological and autoimmune protocols marketed to longevity-focused patients, and IV-based allogeneic products offered by private wellness clinics. The FDA classifies most stem cell injections for orthopedic, neurological, or longevity use as investigational biologics under 21 CFR Part 1271, meaning they require either a Biologics License or an active Investigational New Drug authorization. Autologous bone marrow and adipose products may qualify as Section 361 when minimally manipulated and used for homologous function. SB 1004 (2017) requires written disclosure when stem cell therapy is not FDA-approved. The Medical Board of California regulates physician practice under Business and Professions Code 651. Proposition 71 (2004) established the California Institute for Regenerative Medicine (CIRM). The FDA secured a 2022 permanent injunction against the California Stem Cell Treatment Center over non-compliant adipose SVF products. The 3 Glendale clinics listed below have been reviewed against our vetting criteria, including federal NPI lookup, OIG exclusion screening, and California Medical Board licensure checks.

1 Clinics

Revive Wellness & Rejuvenation

Glendale, AZ

Revive Wellness & Rejuvenation, a regenerative medicine clinic in Glendale, Arizona, specializes in hormone replacement therapy and testosterone replacement therapy alongside peptide protocols and ce…

  • PRP Therapy
  • Shockwave Therapy
  • IV Therapy
  • Arthritis Treatment
  • Peptide Therapy
15 30 50 results per page

Regulatory context

A note on Arizona's stem cell therapy rules.

In Arizona, cellular products are governed by federal rules under 21 CFR Part 1271. Products that are minimally manipulated and used for homologous use fall under Section 361 and do not require premarket approval. Products that are more than minimally manipulated, used non-homologously, or combined with another article are regulated as biological drugs under Section 351 and require an Investigational New Drug application or Biologics License Application. Most adipose-derived stromal vascular fraction and culture-expanded stem cell procedures marketed for orthopedic, neurologic, or longevity indications are Section 351 products.

  • Arizona Revised Statutes Title 32, Chapter 13 (Medical Practice Act)
    Establishes physician licensure and scope of practice under the Arizona Medical Board, including standards that apply to regenerative procedures performed by MDs.
  • Arizona Revised Statutes Title 32, Chapter 17 (Osteopathic Practice Act)
    Governs DO licensure and disciplinary authority relevant to cellular therapy administration.
  • Arizona Revised Statutes Title 32, Chapter 18 (Pharmacy Act) and Board of Pharmacy Rules
    Regulates compounding activities including 503A and 503B pharmacy involvement in biologic preparations.

The FDA has issued warning letters and untitled letters to stem cell providers operating in Arizona for marketing unapproved biological products. Arizona is home to several high-profile regenerative clinics, and FDA inspections in the state have cited violations of current good manufacturing practice and unapproved drug claims. The Arizona Medical Board has disciplined physicians for unprofessional conduct tied to misleading advertising of stem cell outcomes. No statewide injunction parallel to the US v California Stem Cell Treatment Center case has been issued in Arizona, but enforcement exposure remains elevated.

Sources: fda.gov · azleg.gov · azmd.gov

Stem Cell Therapy in Glendale, answered.

Most stem cell therapies at private Glendale clinics are not FDA-approved. The FDA has approved certain hematopoietic stem cell products for blood and immune disorders, but stem cell injections for orthopedic, neurological, or longevity use are generally investigational. They require a Biologics License or an active Investigational New Drug authorization, or they must qualify as Section 361 minimally manipulated and homologous-use products under 21 CFR Part 1271. SB 1004 (2017) requires written disclosure when stem cell therapy is not FDA-approved.

Glendale sits in the premium metro tier. Single-joint autologous bone marrow or adipose injections typically run $5,000 to $15,000 per session. Systemic IV protocols using allogeneic umbilical cord or Wharton's jelly products range $10,000 to $25,000, and full multi-session protocols can reach $20,000 to $50,000. Exosome add-ons range $4,000 to $8,000. Insurance rarely covers these treatments because the FDA classifies most protocols as investigational.

Autologous stem cells come from your own body, usually harvested from bone marrow aspirate or adipose tissue and reinjected the same day. When minimally manipulated and used for homologous function, they often fall under FDA Section 361, which does not require pre-market approval. Allogeneic stem cells come from a donor source, most commonly umbilical cord blood or Wharton's jelly, and are generally classified as Section 351 biologics that require an active Investigational New Drug authorization. Glendale clinic offerings span both categories, so ask which classification applies before treatment.

Yes. Research programs at Adventist Health Glendale, USC Verdugo Hills, and nearby Keck Medicine periodically run FDA-authorized stem cell trials across orthopedics, neurology, cardiology, and oncology. Search clinicaltrials.gov and filter by Glendale or the broader metro to see active recruiting studies. Trial participation is typically low-cost or free compared to commercial protocols and includes structured follow-up with imaging and lab monitoring.

Verify physician licensure through the California Medical Board and confirm the clinic's NPI number through the NPPES registry. Check the FDA warning letter database for the clinic name and the HHS Office of Inspector General exclusion list. Ask whether the treatment is Section 361 or Section 351, whether the clinic operates under an Investigational New Drug authorization for allogeneic or expanded products, and whether adverse events are tracked. Ask specifically about compliance with SB 1004.

Treatment guide

Learn about Stem Cell Therapy

What it is, how it works, and what to expect.

Filters

Rating

Treatments

Advanced Therapies 1
Chronic, Immune & Hormonal
Digestive & Respiratory
IV & Infusion
Pain & Musculoskeletal
Skin & Aesthetics
Mental Health & Neurology